Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Clinical trial NCT02464657 · COMPLETED
Trial details
- NCT number
- NCT02464657
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2020-05-07
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.